production and quality control of 166ho-chitosan for therapeutic applications

Authors

samaneh zolghadri

amir reza jalilian

hassan yousefnia

ali bahrami-samani

simindokht shirvani-arani

abstract

introduction: in this research, [166ho]holmium chitosan complex production is described in details, followed by determination of complex radiochemical purity, stability and biodistribution (after intra-articular injection) in wild-type male rats. finally a ho-166 based chitosan kit for ultimate radiosynovectomy as well as radiotherapy applications was developed.methods: 166ho-chitosan complex was prepared using chitosan concentrations and 166hocl3 followed by intra-articular injection and biodistribution studies in wild-type rats including and excluding injected knee.results: the [166ho]holmium chitosan complex was prepared with high radiochemical yield (>95 %) in the optimized condition (35mg/3ml of chitosan  in %1 acoh, ph. 3, >98%, itlc) was injected to wild-type rats followed by the biodistribution studies of the compound among the tissues excluding the injected knee data. intra-articular injection of [166ho]holmium chitosan complex to male wild-type rats and investigation of leakage of activity in  the body showed that most of injected dose has remained in injection site 144 h after injection. conclusion: successful development and formulation of 166ho-chitosan kit is described. this kit has the potential for use in clinical setting namely for radiosynovectomy and cancer radiochemotherapy.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Production and quality control of 166Ho-Chitosan for therapeutic applications

Introduction: In this research, [166Ho]Holmium chitosan complex production is described in details, followed by determination of complex radiochemical purity, stability and biodistribution (after intra-articular injection) in wild-type male rats. Finally a Ho-166 based chitosan kit for ultimate radiosynovectomy as well as radiotherapy applications was developed. Methods: 166</s...

full text

Production and Quality Control of Ho-Chitosan for Therapeutic Applications

Introduction: In this research, [Ho]Holmium chitosan complex production is described in details, followed by determination of complex radiochemical purity, stability and biodistribution (after intra-articular injection) in wild-type male rats. Finally a Ho-166 based chitosan kit for ultimate radiosynovectomy as well as radiotherapy applications was developed. Methods: Ho-chitosan complex was pr...

full text

Production, Quality Control and Pharmacokinetic Studies of 166Ho-EDTMP for Therapeutic Applications

(166)Ho-EDTMP is a major therapeutic agent which is widely used in bone palliation therapy. In this study, a (166)Ho-EDTMP complex was prepared successfully using an in-house synthesized EDTMP ligand and (166)HoCl(3). Ho-166 chloride was obtained by thermal neutron irradiation (1 Ã 10(13) ncm(â2)s(â1)) of natural Ho(NO(3))(3) samples (specific activity = 3â5 GBq/mg), dissolved in acidic media. ...

full text

Production, Quality Control and Biological Evaluation of 166Ho-PDTMP as a Possible Bone Palliation Agent

Objective(s):In this study, 166Ho-1,2-propylene di-amino tetra(methy1enephosphonicAcid) (166Ho-PDTMP) complex  was prepared as a bone palliation agent. Materials and Methods:The complex was successfully prepared using an in-house synthesized EDTMP ligand and 166HoCl3. Ho-166 chloride was obtained by thermal neutron irradiation (1 × 1013 n.cm-2.s-1) of natural Ho(NO3)3 samples  followed by radio...

full text

Production, quality control and imaging of 64Cu-ATSM in healthy rabbits for clinical applications

  Introduction: [64Cu]diacetyl-bis(N4-methylthiosemicarbazone) ([64Cu]ATSM) is a well-established hypoxia imaging tracer with reproducible production and significant specifity. In this work the high yield production and quality control as well as imaging studies in healthy rabbits is reported. Methods: Copper-64 produced ...

full text

Preparation and quality control of 177Lu-chitosan for radiosynovectomy

Introduction: Rheumatoid arthritis (RA) is the most common autoimmune disease, leading to the destruction of the joints and causing pain, disability, and immobility in the patients. Radiosynovectomy (RSV) has been applied as an effective treatment for the patients with resistant synovitis after failure of long-term pharmacotherapy and intra-articular steroid injection for more than 50 years. Se...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of nuclear medicine

Publisher: tehran university of medical sciences

ISSN 1681-2824

volume 18

issue 2 2010

Keywords
[ ' c h i t o s a n ' , ' h o l m i u m ' , 1 6 6 , ' h e p a t i c c a n c e r ' , ' r a d i o s y n o v e c t o m y ' , ' b i o d i s t r i b u t i o n ' ]

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023